Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland September 6-8, 2000

Radiation Research

Volumn 157, Issue 2, 2002, Pages 204-223

  Stone, Helen B ^a   McBride, William H ^a   Coleman, C Norman ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RADIOTHERAPY; CONFERENCE PAPER; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIOSENSITIVITY;

EID: 0036152222     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2002)157[0204:MNTDP]2.0.CO;2     Document Type: Conference Paper

References (159)

1. Persistent and late occurring lesions in irradiated feet of rats: Their clinical relevance
2. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
3. The importance of vascular damage in the development of late radiation effects in normal tissues
4. Mechanisms of late radiation injury in the spinal cord
5. The pathobiology of late effects of irradiation
6. Normal tissue radiobiology: From the laboratory to the clinic
7. Radiation response of the central nervous system
8. Chronic neuroendocrinological sequelae of radiation therapy
9. Late effects of radiation on the eye and ocular adnexa
10. Late effects of radiation therapy in the head and neck region
11. Thyroid abnormalities after therapeutic external radiation
12. Pathophysiology of irradiated skin and breast
13. Injury to the lung from cancer therapy: Clinical syndromes, measurable end points, and potential scoring systems
14. Radiation injury to the heart
15. Late effects of radiation therapy on the gastrointestinal tract
16. Hepatic toxicity resulting from cancer treatment
17. Clinical radiation nephropathy
18. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy
19. Late injury of cancer therapy on the female reproductive tract
20. Response of growing bone to irradiation: A proposed late effects scoring system
21. Late radiation injury to muscle and peripheral nerves
22. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
23. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
24. LENT: A good beginning but
25. Complicating issues in complication reporting
26. The impact on quality of life by radiation late effects
27. Understanding radiation damage in late effect normal tissues: Learning to negotiate the dose-volume-complication terrain or waiting for Godot?
28. Late Effects toxicity scoring: The SOMA scale
29. Overview. Late Effects of Normal Tissues (LENT) scoring system
30. LENT SOMA scales for all anatomic sites
31. About tolerance and quality. An important notice to all radiation oncologists
32. Late effects toxicity scoring: The SOMA scale
33. Introduction. Late effects consensus conference: RTOG/EORTC
34. Overview of late effects normal tissues (LENT) scoring system
35. LENT SOMA tables
36. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse
37. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis
38. Murine strain differences in the volume effect and incidence of radiation-induced colorectal obstruction
39. Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base
40. Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms
41. Acute and late reactions to radiation therapy in patients with collagen vascular diseases
42. Irradiation in the setting of collagen vascular disease: Acute and late complications
43. Bacterial superantigen staphylococcal enterotoxin B induces interstitial pneumonia in SCID mice reconstituted with peripheral blood mononuclear cells from collagen vascular disease patients
44. Familial clustering of end-stage renal disease in blacks with lupus nephritis
45. Genotype-phenotype relationship in inflammatory bowel disease
46. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?
47. A neural network to predict symptomatic lung injury
48. Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ
49. The effect of local and systemic irradiation on impairment of wound healing in mice
50. Hypoxia in radiation-induced blood-spinal cord barrier breakdown
51. Changes in the microcirculation of normal tissues after irradiation
52. Early wound healing exhibits cytokine surge without evidence of hypoxia
53. Radiation-induced hypoxia may perpetuate late normal tissue injury
54. Review of methods used to study oxygen transport at the microcirculatory level
55. Oxygen in human tumors: Correlations between methods of measurement and response to therapy
56. From wound to scar
57. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
58. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
59. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis
60. Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and -sensitive mice after thoracic irradiation
61. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: Modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis
62. Cytokine cascades in late normal tissue radiation responses
63. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis
64. The role of T-cells in radiation pneumonitis after bone marrow transplantation
65. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat
66. Acceleration of tissue repair by transforming growth factor beta 1: Identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits
67. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury
68. Chronic lymphocytic alveolitis with migrating pulmonary infiltrates after localized chest wall irradiation
69. Bilateral lymphocytic alveolitis: A common reaction after unilateral thoracic irradiation
70. Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation
71. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer
72. Chemokines and CD40 expression in human fibroblasts
73. TGF-β1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype
74. Accumulation of P-selectin in the lumen of irradiated blood vessels
75. Cutaneous wound healing
76. Loss of Smad3 modulates wound healing
77. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
78. Transforming growth factor-beta activation in irradiated murine mammary gland
79. Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland
80. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
81. Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice
82. Mediators and mechanisms of radiation nephropathy
83. TGF-β1 production in radiation nephropathy: Role of angiotensin II
84. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
85. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis
86. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor
87. M6P/IGF2R is mutated in squamous cell carcinoma of the lung
88. Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma
89. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
90. M6P/IGF2 receptor: A candidate breast tumor suppressor gene
91. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
92. Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair
93. Differential expression of collagen types I and III in consequential and primary fibrosis in irradiated mouse colon
94. Radiation biology at clinically relevant fractions
95. Pathogenesis of liver fibrosis: Role of oxidative stress
96. Hyaluronan in radiation-induced lung disease in the rat
97. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: Studies of clinical samples and in vitro cell lines co-cultured with fibroblasts
98. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator
99. Leukocyte proteinases in wound healing: Roles in physiologic and pathologic processes
100. Protective effect of corticosteroids on radiation pneumonitis in mice
101. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality
102. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice
103. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality
104. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor
105. The effect of steroids on radiation-induced lung-disease in the rat
106. Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis
107. In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice
108. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression
109. Human hematopoietic growth factors: Old lessons and new perspectives
110. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice
111. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair
112. Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease
113. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation
114. The World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments
115. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
116. Pharmacologic modification of radiation-induced late normal tissue injury
117. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker
118. Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist
119. Brief pharmacological intervention in experimental radiation nephropathy
120. Angiotensin II infusion exacerbates radiation nephropathy
121. Effect of captopril on changes in rats' hearts induced by long-term irradiation
122. ACE inhibitors attenuate expression of renal transforming growth factor-β1 in humans
123. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen
124. Chronic radiation proctitis treated with hyperbaric oxygen
125. Role of hyperbaric oxygen therapy in the management of mandibular osteoradionecrosis
126. Hyperbaric oxygen therapy in hemorrhagic radiation cystitis: A report of 20 cases
127. Hyperbaric oxygen therapy for radiation myelitis
128. Hyperbaric oxygen as a prophylaxis for radiation-induced delayed enteropathy
129. Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy
130. Relationship of oxygen dose to angiogenesis induction in irradiated tissue
131. Histomorphometric evaluation of the effect of hyperbaric oxygen treatment on healing around hydroxyapatite implants in irradiated rat bone
132. A model of wound healing in chronically radiation-damaged rat skin
133. Hyperbaric oxygen and basic fibroblast growth factor promote growth of irradiated bone
134. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis
135. Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats
136. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol
137. Modification of late radiation damage in the rectum of rats by deproteinized calf blood serum (ActoHorm) and pentoxifylline (PTX)
138. Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme
139. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: Clinical trial
140. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study
141. Prevention of radioinduced cystitis by orgotein: A randomized study
142. Cu/Zn superoxide dismutase modulates phenotypic changes in cultured fibroblasts from human skin with chronic radiotherapy damage
143. Hypersensitivity reaction after orgotein (superoxide dismutase) administration
144. Systemic anaphylaxis following parenteral orgotein administration
145. Effect of fibroblast implants on wound healing of irradiated skin: Assay of wound strength and quantitative immunohistology of collagen
146. Intradermal injection of autologous dermal fibroblasts improves wound healing in irradiated skin
147. The role of Tc-99m HMPAO functional brain imaging in detection of cerebral radionecrosis
148. Assessment of radiotherapeutic effect on brain tumors by dynamic susceptibility contrast MR imaging: A preliminary report
149. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: Association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy
150. Molecular imaging
151. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy
152. Early detection of radiation-induced glomerular injury by albumin permeability assay
153. M6P/IGF2R imprinting evolution in mammals
154. Imprinted genes as potential genetic and epigenetic toxicologic targets
155. Low-dose hypersensitivity: Current status and possible mechanisms
156. Biologic basis for altered fractionation schemes
157. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients
158. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease
159. Hodgkin's disease - Finding the balance between cure and late effects